Log In
Print this Print this

Influenza Vaccine Enhancement Patch (VEP)

  Manage Alerts
Collapse Summary General Information
Company Valneva SE
DescriptionVaccine patch containing heat-labile enterotoxin from Escherichia coli (LT)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationInfluenza virus
Indication DetailsPrevent H5N1 pandemic influenza
Regulatory Designation
PartnerGlaxoSmithKline plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today